Spyre Therapeutics News

Spyre Therapeutics | 8-K: Current report

Nov 20 06:16

Spyre Therapeutics | 8-K: Current report

Nov 19 05:06

Spyre Therapeutics | 8-K: Current report

Nov 13 01:58

Spyre Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 8 05:23

Spyre Therapeutics | 8-K: Current report

Oct 15 18:22

Spyre Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Sep 21 04:08

Spyre Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Sep 7 04:11

Spyre Therapeutics | 8-K/A: Current report (Amendment)

Aug 9 03:14

Spyre Therapeutics | 8-K: Current report

May 31 04:41

Spyre Therapeutics | 8-K: Current report

May 15 19:45

Spyre Therapeutics | 8-K: Current report

Apr 26 04:26

S-1: General form for registration of securities under the Securities Act of 1933

Apr 20 03:27

Spyre Therapeutics | DEF 14A: Definitive information statements

Apr 2 04:08

Spyre Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 28 02:42

Spyre Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Mar 28 02:42

Spyre Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 20 19:17

Spyre Therapeutics | 8-K: Current report

Mar 18 20:35

Spyre Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 15 04:20

Spyre Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Mar 15 04:16

Spyre Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 6 06:20